Palo Alto Investors »

Vyne Therapeutics shares owned by Palo Alto Investors

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Palo Alto Investors from 13F filings

Historical chart of Palo Alto Investors investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Palo Alto Investors

Quarter filed Position value Share count Share price at filing
2024-06-30 $878k 445k 1.97
2024-03-31 $1.4M 445k 3.07
2023-12-31 $1.0M 445k 2.33